CS
BIO icon

Credit Suisse’s Bio-Rad Laboratories Class A BIO Stock Holding History

Credit Suisse’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,000
Closed -$7.95M – 4088
2019
Q1 		$7.95M Buy
+26,000
New +$7.02M 0.01% 1385

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Credit Suisse's BIO Position: Q1 2024 in Review

Credit Suisse reduced its Bio-Rad Laboratories Class A (BIO) stake by 21% in Q1 2024, selling an estimated $2.19M and leaving 25,397 shares worth $8.78M. The position accounts for 0.01% of the portfolio, ranked #976.

Credit Suisse first reported a position in BIO in Q2 2013 and has held it in 44 quarters since. The position peaked at $88.8M in Q2 2021. 466 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • Credit Suisse held 25,397 shares of Bio-Rad Laboratories Class A worth $8.78M as of Q1 2024.
  • Credit Suisse sold 6,670 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $2.19M.
  • Bio-Rad Laboratories Class A made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #976 holding.
  • Credit Suisse first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Bio-Rad Laboratories Class A position peaked at $88.8M in Q2 2021.
  • 466 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.